Guidance. Clarity. Direction.

Carter, DeLuca & Farrell LLP, a leader in intellectual property law, provides cost-effective services to clients from around the world, protecting innovations in a wide range of technologies.

Throughout the phases of product or brand development, we form a critical part of our clients’ development teams to provide preparation, prosecution and clearance services to maximize protection while navigating through freedom-to-operate challenges. We also provide extensive IP due diligence services and IP asset assimilation to help our clients achieve their business objectives.

Search Attorneys

Events

Dec
8 – 8
2021
Seminar: The Legality of Cannabis and its Impact on IP Rights HostingCarter, DeLuca & Farrell LLP is proud to announce that our partner, Pina Campagna, will be a panelist discussing The Legality of...

CAFC Update

GLAXOSMITHKLINE LLC v. TEVA PHARMACEUTICALS USA, INC. October 2, 2020

GlaxoSmithKline and SmithKline Beecham (collectively, “GSK”) charged Teva Pharmaceuticals with infringement of GSK’s Reissue Patent No. RE40,000 (“the ’000 patent”) directed to carvedilol and related compounds. Trial was held in the District Court; the jury found the patent valid and infringed, and assessed damages. The jury also found that the infringement was willful. The district court then...

BIOGEN MA INC. v. EMD SERONO, INC. September 28, 2020

Biogen MA, Inc. sued EMD Serono, Inc. and Pfizer alleging contributory and induced infringement of Biogen’s U.S. Patent Number 7,588,755 by the sale and marketing in the United States of Rebif, a recombinant interferon-β (“IFN-β”) product used for the treatment of Multiple Sclerosis. After a five-week trial, a jury found that the ’755 patent claims were anticipated...

Biogen MA, Inc. sued EMD Serono, Inc. and Pfizer alleging contributory and induced infringement of Biogen’s U.S. Patent Number 7,588,755 by the sale...

APPLE INC. v. VOIP-PAL.COM, INC. September 25, 2020

Voip-Pal.com, Inc. owns U.S. Patent Nos. 8,542,815 and 9,179,005, both of which are titled “Producing Routing Messages for Voice Over IP Communications” and sued Apple Inc. for infringement. Apple petitioned for inter partes review (“IPR”) of several claims of the Voip-Pal patents. During the IPR proceedings, Voip-Pal’s former CEO sent six letters to various parties (members of Congress, the...

Voip-Pal.com, Inc. owns U.S. Patent Nos. 8,542,815 and 9,179,005, both of which are titled “Producing Routing Messages for Voice Over IP Communications” and...